UCSF & Rockefeller University NY Investigators Call to Accelerate Hidradenitis Suppurativa Research & Improve Care to Move Beyond Burden

Research and development concept. Double exposure image of scientific and medical lab instrument, microscope, test tube and glass flask for microbiology and chemistry in laboratory for medicine study.

University of California, San Francisco and Rockefeller University, New York investigators summarize the imperative of Hidradenitis Suppurativa research. What follows is their abstract and below link to the source.

There is a dearth of high-level evidence guiding our understanding of the epidemiology, pathophysiology, and treatment of hidradenitis suppurativa (HS). Despite an estimated prevalence of 1% in Western populations and quality of life impairment often exceeding other chronic skin diseases, annual HS-related publications lag far behind annual publications for other common and rare skin diseases. Federal funding to study HS wanes in comparison to funding for other chronic cutaneous dermatoses, with only 0.1% of the National Institute of Arthritis and Musculoskeletal and Skin Diseases total research funds for skin diseases dedicated to HS. 

By December 31, 2018, only 17 clinical trials dedicated to HS had been completed in the United States and there is only 1 US Food and Drug Administration (FDA)-approved therapy for HS, compared with numerous trials and nearly a dozen currently FDA-approved systemic medications for psoriasis. The paucity of HS medical knowledge and e...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee